v3.24.1

FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Fair Value Disclosures [Abstract] |
Fair Value Measurement by Fair Value Hierarchy Level | During the periods presented, there were no transfers between fair value hierarchical levels.
|  | Fair Value Measurements at Reporting Date |  |
Description |  | Balance at December 31, 2023 |  | Quoted prices in active markets Level 1 |  | Significant other observable inputs Level 2 |  | Significant unobservable inputs Level 3 |  | Measured at Net Asset Value as a Practical Expedient (2)
|  | (amounts in thousands)
Liabilities |  |  |  |  |  |  |  |  |  |
Deferred compensation plan liabilities (1) |  | $ | 21,045 |  |  | $ | 16,923 |  |  | $ | — |  |  | $ | — |  |  | $ | 4,122 |
Contingent Consideration (4) |  | $ | 31 |  |  | $ | — |  |  | $ | — |  |  | $ | 31 |  |  | $ | — |
Description |  | Balance at December 31, 2022 |  | Quoted prices in active markets Level 1 |  | Significant other observable inputs Level 2 |  | Significant unobservable inputs Level 3 |  | Measured at Net Asset Value as a Practical Expedient (2) |  |
|  | (amounts in thousands) |  |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Interest rate cash flow hedge (3) |  | $ | 4,012 |  |  | $ | — |  |  | $ | 4,012 |  |  | $ | — |  |  | $ | — |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation plan liabilities (1) |  | $ | 24,123 |  |  | $ | 19,944 |  |  | $ | — |  |  | $ | — |  |  | $ | 4,179 |  |  |
Contingent Consideration (4) |  | $ | 12 |  |  | $ | — |  |  | $ | — |  |  | $ | 12 |  |  | $ | — |  |  |
(1)The Company’s deferred compensation liability, which is included in other long-term liabilities, is recorded at fair value on a recurring basis. The unfunded plan allows participants to hypothetically invest in various specified investment options. (2)The fair value of underlying investments in collective trust funds is determined using the net asset value (“NAV”) provided by the administrator of the fund as a practical expedient. The NAV is determined by each fund’s trustee based upon the fair value of the underlying assets owned by the fund, less liabilities, divided by outstanding units. In accordance with appropriate accounting guidance, these investments have not been classified in the fair value hierarchy. (3)The Company’s interest rate collar, which is included in other long-term liabilities at December 31, 2022, is recorded at fair value on a recurring basis. The derivatives are not exchange listed and therefore the fair value is estimated using models that reflect the contractual terms of the derivative, yield curves, and the credit quality of the counterparties. The models also incorporate the Company’s creditworthiness in order to appropriately reflect non-performance risk. Inputs are generally observable and do not contain a high level of subjectivity. The Company exited this interest rate collar during the fourth quarter of 2023 and had no derivative financial instrument agreements outstanding as of December 31, 2023. (4)In connection with the Podcorn Acquisition, the Company recorded a liability for contingent consideration payable based upon the achievement of certain annual performance benchmarks over 2 years. The fair value of the liability is estimated using probability-weighted, discounted future cash flows at current tax rates using a scenario-based model, and remeasured quarterly. The significant unobservable inputs (Level 3) used to estimate the fair value included the projected Adjusted EBITDA values for 2022 and 2023, as defined in the purchase agreement, and the discount rate. This balance is included in other long-term liabilities.
Schedule of Carrying Value of Financial Instruments | The following table presents the carrying value of financial instruments and, where practicable, the fair value as of the periods indicated:
| As of December 31, 2023 |  | As of December 31, 2022
| Carrying Value |  | Fair Value |  | Carrying Value |  | Fair Value
| (amounts in thousands)
Old Term B Loans (1) | $ | 632,415 |  |  | $ | 309,747 |  |  | $ | 632,415 |  |  | $ | 454,548 |
Old Revolver (2) | $ | 220,126 |  |  | $ | 220,126 |  |  | $ | 180,000 |  |  | $ | 180,000 |
Old 2029 Notes (3) | $ | 540,000 |  |  | $ | 10,125 |  |  | $ | 540,000 |  |  | $ | 92,138 |
Old 2027 Notes (3) | $ | 460,000 |  |  | $ | 8,625 |  |  | $ | 460,000 |  |  | $ | 82,513 |
Accounts receivable facility (4) | $ | 75,000 |  |  |  |  | $ | 75,000 |  |  |
Other debt (4) | $ | — |  |  |  |  | $ | 752 |  |  |
Letters of credit (4) | $ | — |  |  |  |  | $ | 6,069 |  |  |
The following methods and assumptions were used to estimate the fair value of financial instruments: (1)The Company’s determination of the fair value of the Old Term B-2 Loan was based on quoted prices for these instruments and is considered a Level 2 measurement as the pricing inputs are other than quoted prices in active markets. (2)The fair value of the Old Revolver was considered to approximate the carrying value as the interest payments are based on SOFR rates that reset periodically. The Old Revolver is considered a Level 2 measurement as the pricing inputs are other than quoted prices in active markets. (3)The Company utilizes a Level 2 valuation input based upon the market trading prices of the Old 2029 Notes and Old 2027 Notes to compute the fair value as these Old 2029 Notes and Old 2027 Notes are traded in the debt securities market. The Old 2029 Notes and Old 2027 Notes are considered a Level 2 measurement as the pricing inputs are other than quoted prices in active markets. (4)The Company does not believe it is practicable to estimate the fair value of the accounts receivable facility, other debt or the outstanding standby letters of credit. The company had no letters of credit outstanding as of December 31, 2023.
Schedule of Cost Method Investments | The following table presents the Company’s investments valued under the measurement alternative:
|  | As of December 31,
Investments Valued Under the Measurement Alternative |  | 2023 |  | 2022
|  | (amounts in thousands)
Investment balance before cumulative impairment as of January 1, |  | $ | 3,005 |  |  | $ | 3,005 |
Accumulated impairment as of January 1, |  | — |  |  | — |
Investment beginning balance after cumulative impairment as of January 1, |  | 3,005 |  |  | 3,005 |
Impairment of investments |  | (1,505) |  |  | — |
Ending period balance |  | $ | 1,500 |  |  | $ | 3,005 |

X
- Definition Tabular presentation of the carrying value of financial instruments and the fair value of the periods indicated. + References No definition available. + Details
Name: | aud_ScheduleOfCarryingValueOfFinancialInstrumentsTableTextBlock
Namespace Prefix: | aud_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration